413 related articles for article (PubMed ID: 18023212)
1. Regulation of hepcidin: insights from biochemical analyses on human serum samples.
Kemna EH; Kartikasari AE; van Tits LJ; Pickkers P; Tjalsma H; Swinkels DW
Blood Cells Mol Dis; 2008; 40(3):339-46. PubMed ID: 18023212
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin and iron deficiency in pre-kidney transplant patients.
Sancho A; Pastor MC; Troya M; Bonal J; Bayés B; Morales-Indiano C; Lauzurica R; Romero R
Transplant Proc; 2009; 41(6):2079-81. PubMed ID: 19715836
[TBL] [Abstract][Full Text] [Related]
3. Serum pro-hepcidin level and iron homeostasis in Japanese dialysis patients with erythropoietin (EPO)-resistant anemia.
Shinzato T; Abe K; Furusu A; Harada T; Shinzato K; Miyazaki M; Kohno S
Med Sci Monit; 2008 Sep; 14(9):CR431-7. PubMed ID: 18758412
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery.
Tussing-Humphreys LM; Nemeth E; Fantuzzi G; Freels S; Holterman AX; Galvani C; Ayloo S; Vitello J; Braunschweig C
Obesity (Silver Spring); 2010 Oct; 18(10):2010-6. PubMed ID: 20075851
[TBL] [Abstract][Full Text] [Related]
5. Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children.
Aeberli I; Hurrell RF; Zimmermann MB
Int J Obes (Lond); 2009 Oct; 33(10):1111-7. PubMed ID: 19636315
[TBL] [Abstract][Full Text] [Related]
6. Serum prohepcidin levels in children with solid tumors, inflammatory bowel disease and iron deficiency anemia.
Kaya Z; Yildiz E; Gursel T; Albayrak M; Kocak U; Karadeniz C; Dalgiç B
J Trop Pediatr; 2011 Apr; 57(2):120-5. PubMed ID: 20601378
[TBL] [Abstract][Full Text] [Related]
7. Maternal pro-hepcidin at term correlates with cord blood pro-hepcidin at birth.
Ervasti M; Sankilampi U; Luukkonen S; Heinonen S; Punnonen K
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):161-5. PubMed ID: 19740590
[TBL] [Abstract][Full Text] [Related]
8. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy.
Malyszko J; Malyszko JS; Mysliwiec M
Kidney Blood Press Res; 2009; 32(4):235-8. PubMed ID: 19713706
[TBL] [Abstract][Full Text] [Related]
9. Serum transferrin receptor.
Skikne BS
Am J Hematol; 2008 Nov; 83(11):872-5. PubMed ID: 18821709
[TBL] [Abstract][Full Text] [Related]
10. Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI).
Sasu BJ; Li H; Rose MJ; Arvedson TL; Doellgast G; Molineux G
Blood Cells Mol Dis; 2010 Oct; 45(3):238-45. PubMed ID: 20800515
[TBL] [Abstract][Full Text] [Related]
11. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
Costa E; Pereira BJ; Rocha-Pereira P; Rocha S; Reis F; Castro E; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
Am J Nephrol; 2008; 28(4):677-83. PubMed ID: 18354252
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin expression in patients with acute leukaemia.
Cheng PP; Sun ZZ; Jiang F; Tang YT; Jiao XY
Eur J Clin Invest; 2012 May; 42(5):517-25. PubMed ID: 22023453
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
Chang J; Bird R; Clague A; Carter A
Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
[TBL] [Abstract][Full Text] [Related]
14. Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.
Kato A; Tsuji T; Luo J; Sakao Y; Yasuda H; Hishida A
Am J Nephrol; 2008; 28(1):115-21. PubMed ID: 17943020
[TBL] [Abstract][Full Text] [Related]
15. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
[TBL] [Abstract][Full Text] [Related]
16. Does hepcidin affect erythropoiesis in hemodialysis patients?
Eleftheriadis T; Kartsios C; Liakopoulos V; Antoniadi G; Ditsa M; Papadopoulos C; Anifandis G; Skirta A; Markala D; Stefanidis I
Acta Haematol; 2006; 116(4):238-44. PubMed ID: 17119323
[TBL] [Abstract][Full Text] [Related]
17. Iron regulation and erythropoiesis.
Nemeth E
Curr Opin Hematol; 2008 May; 15(3):169-75. PubMed ID: 18391780
[TBL] [Abstract][Full Text] [Related]
18. Pro-hepcidin and iron metabolism parameters in multi-time blood donors.
Boinska J; Zekanowska E; Kwapisz J
Int J Lab Hematol; 2010 Oct; 32(5):483-90. PubMed ID: 19968722
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of and correspondence among different hepcidin forms in blood and urine and their relationships to iron status in healthy, male Guatemalan volunteers observed over 9 weeks.
Schuemann K; Solomons NW; Laarakkers CM; Romero-Abal ME; Kroll S; Weiss G; Swinkels DW
Ann Nutr Metab; 2011; 58(2):158-66. PubMed ID: 21654163
[TBL] [Abstract][Full Text] [Related]
20. Improved preoperative iron status assessment by soluble transferrin receptor in elderly patients undergoing knee and hip replacement.
Basora M; Deulofeu R; Salazar F; Quinto L; Gomar C
Clin Lab Haematol; 2006 Dec; 28(6):370-5. PubMed ID: 17105489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]